H7N9 live influenza vaccine (Research Institute of Influenza)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH7N9 live influenza vaccine (Research Institute of Influenza)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesWorld Health Organization Institute Of Experimental Medicine Of The Russian Academy Of Medical Sciences

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Experimental Medicine Of The Russian Academy Of Medical Sciences

Inactive CompaniesWorld Health Organization Smorodintsev Research Institute Of Influenza

Active IndicationsInfluenza, Human

Inactive IndicationsDrug-Related Side Effects and Adverse Reactions

Other Information

ATC CodeN/A